14-day Premium Trial Subscription Try For FreeTry Free
Looking for the best penny stocks to watch right now? Check these 7 out The post Which Penny Stocks Are Investors Buying Right Now?

Why Clearside Biomedical Stock Surged Today

03:38pm, Thursday, 17'th Jun 2021
Analysts are excited about the biotech's investigational treatment for a common eye disorder.

Why Opthea Stock Skyrocketed Today

04:06pm, Wednesday, 16'th Jun 2021
The big gain appears to be a sympathy move related to positive news for another drugmaker.

4 Penny Stocks Reddit Traders Are Buying Right Now

11:46am, Wednesday, 16'th Jun 2021
Looking for penny stocks to buy on Reddit? Check these 4 out for your watchlist The post 4 Penny Stocks Reddit Traders Are Buying Right Now appeared first on Penny Stocks to Buy, Picks, News and Infor
Investors need to pay close attention to Clearside Biomedical (CLSD) stock based on the movements in the options market lately.

CLSD Stock Price Increased 37.75%: Why It Happened

07:40am, Wednesday, 16'th Jun 2021
The stock price of Clearside Biomedical, Inc. (Nasdaq: CLSD) increased 37.75% yesterday. This is why it happened.
Today, investors in CLSD stock are seeing gains of nearly 50% as the company announced positive results from one of its clinical trials. The post CLSD Stock: The Big News Lifting Clearside Biomedical
Shares of Clearside Biomedical, Inc. (NASDAQ: CLSD) are skyrocketing Tuesday morning after the company announced positive safety results for a treatment for eye diseases. If Clearside makes it to the
The stock price of Clearside Biomedical Inc (NASDAQ: CLSD) increased by over 35% pre-market. This is why it happened.
- CLS-AX 0.03 mg dose delivered via suprachoroidal injection was well-tolerated with no treatment related adverse events -
ALPHARETTA, Ga., June 09, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vi
Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q1 2021 Results - Earnings Call Transcript

Recap: Clearside Biomedical Q1 Earnings

04:36pm, Monday, 17'th May 2021
Shares of Clearside Biomedical (NASDAQ:CLSD) rose after the company reported Q1 results. Quarterly Results Earnings per share decreased 85.71% over the past year to ($0.13), which missed the estimate
- Recent New Drug Application Resubmission for XIPERE TM

ScPharmaceuticals: The Third Time's A Charm

09:11am, Wednesday, 12'th May 2021
ScPharmaceuticals: The Third Time's A Charm
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE